首页> 外文OA文献 >Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital
【2h】

Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital

机译:三级护理医院重症监护区产金属β-内酰胺酶的铜绿假单胞菌和不动杆菌的流行

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A total of 39 non-duplicate isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species isolated from blood and endotracheal secretions were tested for metallo-β-lactamase (MBL) production by modified-EDTA disc synergy and double disc synergy tests. The prevalence of MBLs was 33.33% by both the above tests. All patients with MBL-positive isolates were multidrug resistant and had multiple risk factors like > 8 days hospital stay, catheterization, IV lines, previous antibiotic use, etc. These were risk factors for imipenem resistance also. The overall mortality in MBL-positive patients was 46.15%.
机译:从血液和气管内分泌物中分离出的总共39个对碳青霉烯耐药的铜绿假单胞菌和不动杆菌属的非重复菌株通过改良的EDTA盘协同作用和双盘协同作用测试了金属β-内酰胺酶(MBL)的产生。通过以上两个测试,MBL的患病率为33.33%。所有MBL阳性分离株的患者均具有多重耐药性,并具有多种危险因素,例如住院天数> 8天,导管插入,静脉输液,先前使用抗生素等。这些也是亚胺培南耐药的危险因素。 MBL阳性患者的总死亡率为46.15%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号